**Job Description**
This project aims to validate a novel LNP-free delivery strategy for RNA therapeutics, such as siRNA and antisense oligonucleotides (ASOs), to overcome the inefficient delivery of nucleic acid-based therapeutics to the cytosol. Funded by a Distinguished Innovator Grant from the Novo Nordisk Foundation, the project focuses on optimizing the RNA delivery platform through in vitro screening models, followed by in vivo safety and proof-of-concept studies under the supervision of Professor Claus Elsborg Olesen.
**Skills & Abilities**
• Good interpersonal skills, inclusive and team-oriented.
• Able to contribute to a good work environment.
• Fluent in oral and written English.
**Qualifications**
Required Degree(s) in:
• Cell Biology
• Molecular Biology
• Biochemistry
• Related discipline
**Experience**
Other:
• Experience with siRNA, lipid nanoparticles (LNPs), and conjugation approaches such as click chemistry will be considered a strong advantage.
Note: We’ve analyzed the actual job post using AI, for more details visit the original job post by clicking on “Apply Now”!
